Described herein are pharmaceutical packaging systems which reduce oxidative degradation of morphine, hydromorphone, promethazine and various oxygen-delicate medicines, this sort of methods including a syringe having an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging